BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26134042)

  • 21. Maximum activities of some key enzymes of glycolysis, glutaminolysis, Krebs cycle and fatty acid utilization in bovine pulmonary endothelial cells.
    Leighton B; Curi R; Hussein A; Newsholme EA
    FEBS Lett; 1987 Dec; 225(1-2):93-6. PubMed ID: 3691808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
    Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
    Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells.
    Brusselmans K; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
    Int J Cancer; 2003 Oct; 106(6):856-62. PubMed ID: 12918062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyunsaturated and saturated fatty acids-rich diets and immune tissues. 2. Maximal activities of key enzymes of glutaminolysis, glycolysis, pentose-phosphate-pathway and Krebs cycle in thymus, spleen and mesenteric lymph nodes.
    GuimarĂ£es AR; Sitnik RH; Curi CM; Curi R
    Biochem Int; 1990 Dec; 22(6):1015-23. PubMed ID: 2090103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fatty acid synthase: a new anti-tumor target].
    Puig T; Porta R; Colomer R
    Med Clin (Barc); 2009 Mar; 132(9):359-63. PubMed ID: 19268984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of desoxyrhaponticin and rhaponticin, two natural stilbene glycosides from the Tibetan nutritional food Rheum tanguticum Maxim. ex Balf., on fatty acid synthase and human breast cancer cells.
    Li P; Tian W; Wang X; Ma X
    Food Funct; 2014 Feb; 5(2):251-6. PubMed ID: 24362821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms of fatty acid synthase (FASN)-mediated resistance to anti-cancer treatments.
    Wu X; Qin L; Fako V; Zhang JT
    Adv Biol Regul; 2014 Jan; 54():214-21. PubMed ID: 24080588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologically Inferred Glycolysis and Glutaminolysis Requirement of B Cells in Lupus-Prone Mice.
    Choi SC; Li W; Zhang X; Kanda N; Zeumer-Spataro L; Teng X; Morel L
    J Immunol; 2022 May; 208(9):2098-2108. PubMed ID: 35387839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology.
    Kuhajda FP
    Nutrition; 2000 Mar; 16(3):202-8. PubMed ID: 10705076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic and toxicologic evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells.
    Deepa PR; Vandhana S; Jayanthi U; Krishnakumar S
    Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):494-503. PubMed ID: 22151915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress in Metabolic Studies of Gastric Cancer and Therapeutic Implications.
    Romo-Perez A; Dominguez-Gomez G; Chavez-Blanco A; Taja-Chayeb L; Gonzalez-Fierro A; Diaz-Romero C; Lopez-Basave HN; Duenas-Gonzalez A
    Curr Cancer Drug Targets; 2022; 22(9):703-716. PubMed ID: 35422220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deciphering Fatty Acid Synthase Inhibition-Triggered Metabolic Flexibility in Prostate Cancer Cells through Untargeted Metabolomics.
    Oh JE; Jung BH; Park J; Kang S; Lee H
    Cells; 2020 Nov; 9(11):. PubMed ID: 33182594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural fatty acid synthase inhibitors as potent therapeutic agents for cancers: A review.
    Zhang JS; Lei JP; Wei GQ; Chen H; Ma CY; Jiang HZ
    Pharm Biol; 2016 Sep; 54(9):1919-25. PubMed ID: 26864638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lonidamine as a modulator of taxol activity in human ovarian cancer cells: effects on cell cycle and induction of apoptosis.
    Orlandi L; Zaffaroni N; Bearzatto A; Villa R; De Marco C; Silvestrini R
    Int J Cancer; 1998 Oct; 78(3):377-84. PubMed ID: 9766575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of fatty acid synthase by Orlistat accelerates gastric tumor cell apoptosis in culture and increases survival rates in gastric tumor bearing mice in vivo.
    Dowling S; Cox J; Cenedella RJ
    Lipids; 2009 Jun; 44(6):489-98. PubMed ID: 19381703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
    Menendez JA; Vellon L; Oza BP; Lupu R
    J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells.
    Menendez JA; Lupu R
    Arch Immunol Ther Exp (Warsz); 2004; 52(6):414-26. PubMed ID: 15577743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model.
    Carvalho MA; Zecchin KG; Seguin F; Bastos DC; Agostini M; Rangel AL; Veiga SS; Raposo HF; Oliveira HC; Loda M; Coletta RD; Graner E
    Int J Cancer; 2008 Dec; 123(11):2557-65. PubMed ID: 18770866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.